Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report

Authors :: Wu, Zhichao
Luu, Chi D.
Hodgson, Lauren A.B.
Caruso, Emily
Brassington, Kate H.
Tindill, Nicole
Aung, Khin Zaw
Harper, Colin A.
Wickremasinghe, Sanjeewa S.
Sandhu, Sukhpal S.
McGuinness, Myra B.
Chen, Fred K.
Chakravarthy, Usha
Arnold, Jennifer J.
Heriot, Wilson J.
Durkin, Shane R.
Wintergerst, Maximilian W.M.
Gorgi Zadeh, Shekoufeh
Schultz, Thomas
Finger, Robert P.
Cohn, Amy C.
Baglin, Elizabeth K.
Sharangan, Pyrawy
Guymer, Robyn H.
Source :: Ophthalmology Retina; December 2019, Vol. 3 Issue: 12 p1026-1034, 9p
Publication Year :: 2019
Abstract: To evaluate the secondary and exploratory outcomes of the Laser Intervention in Early Stages of Age-Related Macular Degeneration (LEAD) study, a 36-month trial of a subthreshold nanosecond laser (SNL) treatment for slowing the progression to late age-related macular degeneration (AMD) in its early stages.

Full Text Access

Tools